Stembionics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 1.57%
- Profit Growth 14.76%
- Ebitda 8.66%
- Net Worth 9.18%
- Total Assets 9.18%
About Stembionics
Stembionics Private Limited (SPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 July 2016 (Eight years and six months 13 days old ). Its registered office is in Howrah, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Soumi Paul and Manibrata Paul serve as directors at the Company.
Company Details
-
Location
Howrah, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999WB2016PTC216884
-
Company No.
216884
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jul 2016
-
Date of AGM
09 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Stembionics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Soumi Paul
|
Additional Director | 26-Jul-2021 | Current |
|
Manibrata Paul
|
Director | 29-Jul-2016 | Current |
Financial Performance of Stembionics.
Stembionics Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 1.57% increase. The company also saw a substantial improvement in profitability, with a 14.76% increase in profit. The company's net worth moved up by a moderate rise of 9.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stembionics?
Unlock access to Stembionics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Bomlife Private LimitedManibrata Paul is a mutual person
-
Shilabati Biosphere Private LimitedSoumi Paul and Manibrata Paul are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Stembionics?
Unlock and access historical data on people associated with Stembionics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stembionics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stembionics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
